Track the Seelos Therapeutics, INC. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Seelos Therapeutics, INC. has recorded 9 public disclosures. Market capitalisation: €58. The latest transaction was filed on 1 March 2024 (Attribution). Among the most active insiders: Golembiewski Michael Joseph. Every trade is free.
9
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
12,500 shares@ €0.8058100.0% of flowCommon StockSEC:0001136261-22-000155:0
9 of 9 declarations
Acerca de Seelos Therapeutics, INC.
Seelos Therapeutics, INC. es una empresa biofarmacéutica enfocada en desarrollar tratamientos para trastornos neurológicos y psiquiátricos. Está cotizada en NASDAQ bajo el símbolo SEEL.